Candida invasion and influences in smoking patients with multiple oral leucoplakias - a retrospective study

Mycoses

Volumn 54, Issue 5, 2011, Pages

  Chiu, Chang Ta ^a,b,c   Li, Chien Feng ^d   Li, Jau Rong ^e   Wang, Johnny ^f   Chuang, Ching Ya ^b   Chiang, Wei Fan ^d,g   Huang, Shan Chen ^a,b   Chang, Sung Wen ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^c TAINAN SIN LAU HOSPITAL   (Taiwan)

^d CHI MEI MEDICAL CENTER   (Taiwan)

^e NATIONAL KAOHSIUNG NORMAL UNIVERSITY   (Taiwan)

^f UNIVERSITY OF WASHINGTON   (United States)

^g NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Candida; Epithelial dysplasia; Multiple oral leucoplakias; Oral leucoplakia; Smoking

Indexed keywords

ARTICLE; CANDIDIASIS; CIGARETTE SMOKING; DISEASE ASSOCIATION; EPITHELIUM DYSPLASIA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INCIDENCE; INFECTION RATE; LEUKOPLAKIA; MAJOR CLINICAL STUDY; MULTIPLE ORAL LEUKOPLAKIA; ORAL SURGERY; PERIODIC ACID SCHIFF STAIN; PRIORITY JOURNAL; RECURRENCE RISK; RECURRENT DISEASE; RETROSPECTIVE STUDY; RISK ASSESSMENT;

CANDIDA; CANDIDIASIS; FEMALE; HUMANS; INCIDENCE; LEUKOPLAKIA; MALE; RETROSPECTIVE STUDIES; SMOKING;

CANDIDA;

EID: 80052813483     PISSN: 09337407     EISSN: 14390507     Source Type: Journal    
DOI: 10.1111/j.1439-0507.2010.01927.x     Document Type: Article

References (42)

1. Bouquot JE. Oral leukoplakia and erythroplakia: a review and update. Pract Periodontics Aesthet Dent 1994; 6: 9-17.
2. Regezi JA, Sciubba J. Oral Pathology: Clinical-Pathologic Correlations, 2nd edn. Philadelphia, PA: WB Saunders, 1993: 104-9.
3. Ishii J, Fujita K, Komori T. Laser surgery as a treatment for oral leukoplakia. Oral Oncol 2003; 39: 759-69.
4. Banoczy J, Gintner Z, Dombi C. Tobacco use and oral leukoplakia. J Dent Educ 2001; 65: 322-7.
5. Shiu MN, Chen TH, Chang SH, Hahn LJ. Risk factors for leukoplakia and malignant transformation to oral carcinoma: a leukoplakia cohort in Taiwan. Br J Cancer 2000; 82: 1871-4.
6. Thomas G, Hashibe M, Jacob BJ et al. Risk factors for multiple oral premalignant lesions. Int J Cancer 2003; 107: 285-91.
7. Jang SJ, Chiba I, Hirai A, Hong WK, Mao L. Multiple oral squamous epithelial lesions: are they genetically related? Oncogene 2001; 20: 2235-42.
8. Gabriel DD, John PJ, Mark ABM, Ryan LP. Clinical implications and utility of field cancerization. Cancer Cell Int 2007; 7: 2.
9. McCullough MJ, Savage NW. Oral candidosis and the therapeutic use of antifungal agents in dentistry. Aust Dent J 2005; 50: S36-9.
10. Soysa NS, Ellepola AN. The impact of cigarette/tobacco smoking on oral candidosis: an overview. Oral Dis 2005; 11: 268-73.
11. Berman J, Sudbery PE. Candida albicans: a molecular revolution built on lessons from budding yeast. Nat Rev Genet 2002; 3: 918-30.
12. Sitheeque MA, Samaranayake LP. Chronic hyperplastic candidosis/candidiasis (candidal leukoplakia). Crit Rev Oral Biol Med 2003; 14: 253-67.
13. van der Waal I, Schepman KP, van der Meij EH, Smeele LE. Oral leukoplakia: a clinicopathological review. Oral Oncol 1997; 33: 291-301.
14. Lumerman H, Freedman P, Kerpel S. Oral epithelial dysplasia and the development of invasive squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1995; 79: 321-9.
15. Wright A, Shear M. Epithelial dysplasia immediately adjacent to oral squamous cell carcinomas. J Oral Pathol 1985; 14: 559-64.
16. Ali A, Natah S, Konttinen Y. Differential expression of Toll-like receptors in chronic hyperplastic candidosis. Oral Microbiol Immunol 2008; 23: 299-307.
17. Roed-Petersen B, Renstrup G, Pindborg JJ. Candida in oral leukoplakias. A histologic and exfoliative cytologic study. Scand J Dent Res 1970; 78: 323-8.
18. Rindum JL, Stenderup A, Holmstrup P. Identification of Candida albicans types related to healthy and pathological oral mucosa. J Oral Pathol Med 1994; 23: 406-12.
19. Silverman S Jr, Gorsky M, Lozada F. Oral leukoplakia and malignant transformation. A follow-up study of 257 patients. Cancer 1984; 53: 563-8.
20. Odds FC. Candida and Candidosis, 2nd edn. London: Baillière Tindall, 1988.
21. Jennings KJ, MacDonald DG. Histological, microbiological and haematological investigations in denture induced stomatitis. J Dent 1990; 5: 34-7.
22. Nagai Y, Takeshita N, Saku T. Histopathologic and ultrastructural studies of oral mucosa with Candida infection. J Oral Pathol Med 1992; 21: 171-5.
23. Zhang KH, Wang HJ, Qin JX. Effect of candidal infection on the hyperplastic oral epithelium. Zhonghua Kou Qiang Yi Xue Za Zhi 1994; 29: 339-41.
24. Krogh P, Hald B, Holmstrup P. Possible mycological etiology of oral mucosal cancer: catalytic potential of infecting Candida albicans and other yeasts in production of N- nitrosobenzylmethylamine. Carcinogenesis 1987; 8: 1543-8.
25. Almeida OP, Scully C. Fungal infections of the mouth. Braz J Oral Sci 2002; 1: 19-26.
26. Willis AM, Coulter WA, Fulton CR et al. Oral candidal carriage and infection in insulin-treated diabetic patients. Diabet Med 1999; 16: 675-9.
27. Samaranayake LP. Host factors and oral candidosis. In: Samaranayake LP, MacFarlane TW (eds), Oral Candidosis. London, UK: Butterworth, 1990: 66-103.
28. Shin ES, Chung SC, Kim YK et al. The relationship between oral Candida carriage and the secretor status of blood group antigens in saliva. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2003; 96: 48-53.
29. Dahlen G, Blomquist S, Carlen A. A retrospective study on the microbiology in patients with oral complaints and oral mucosal lesions. Oral Dis 2009; 15: 65-72.
30. Soll DR. Phenotypic switching. In: Calderone RA (ed.), Candida and Candidiasis. Washington, DC: ASM Press, 2002: 123-42.
31. Critchley IA, Douglas LJ. Isolation and partial characterization of an adhesin from Candida albicans. J Gen Microbiol 1987; 133: 629-36.
32. Saville SP, Lazzell AL, Monteagudo C, Lopez-Ribot JL. Engineered control of cell morphology in vivo reveals distinct roles for yeast and filamentous forms of Candida albicans during infection. Eukaryot Cell 2003; 2: 1053-60.
33. McCullough MJ, Ross BC, Reade PC. Candida albicans: a review of its history, taxonomy, epidemiology, virulence attributes, and methods of strain differentiation. Int J Oral Maxillofac Surg 1996; 25: 136-44.
34. Borg M, Ruechel R. Expression of extracellular acid proteinase by proteolytic Candida spp. during experimental infection of oral mucosa. Infect Immun 1988; 56: 626-31.
35. Zimmermann CF. Immunohistochemischer Nachweis von Candida Protease bei Verschiedenen Manifestationen der Candida-Mykose. DDS Thesis. Göttingen, Germany: Faculty of Medicine, University of Göttingen, 1986.
36. Bennet KR, Reade PC. Salivary immunoglobulin A levels in tobacco smokers and patients with minor aphthous ulceration. Oral Surg Oral Med Oral Pathol 1982; 53: 461-5.
37. van Oijen MG, Slootweg PJ. Oral field cancerization: carcinogen-induced independent events or micrometastatic deposits? Cancer Epidemiol Biomarkers Prev 2000; 9: 249-56.
38. Day GL, Blot WJ, Shore RE et al. Second cancers following oral and pharyngeal cancers: role of tobacco and alcohol. J Natl Cancer Inst 1994; 86: 131-7.
39. Cianfrigkia F, Di-Gregorio DA, Manieri A. Multiple primary tumours in patients with oral squamous cell carcinoma. Oral Oncol 1999; 35: 157-63.
40. Uittamo J, Siikala E, Kaihovaara P, Salaspuro M, Rautemaa R. Chronic candidosis and oral cancer in APECED-patients: production of carcinogenic acetaldehyde from glucose and ethanol by Candida albicans. Int J Cancer 2009; 124: 754-6.
41. Kurkivuori J, Salaspuro V, Kaihovaara P et al. Acetaldehyde production from ethanol by oral streptococci. Oral Oncol 2007; 43: 181-6.
42. Tillonen J, Homann N, Rautio M, Jousimies-Somer H, Salaspuro M. Role of yeasts in the salivary acetaldehyde production from ethanol among risk groups for ethanol-associated oral cavity cancer. Alcohol Clin Exp Res 1999; 23: 1409-15.